Otsuka and Astex’s oral Inaqovi wins European approval for AML
European Commission has approved the oral combination drug for treating newly diagnosed acute myeloid leukaemia.
European Commission has approved the oral combination drug for treating newly diagnosed acute myeloid leukaemia.
What's Your Reaction?
